to accessing quality health care and poor outcomes relative to other women, due to a large intersection of racism, sexism, and enacted HIV stigma creating a mutually constituted vulnerability. Most work on enacted HIV stigma has focused on HIV-specific outcomes and mental health (Darlington & Hutson, 2017; Earnshaw & Chaudoir, 2009; Katz et al., 2013; Mahajan et al., 2008; Sengupta, Banks, Jonas, Miles, & Smith, 2011; Stangl, Lloyd, Brady, Holland, & Baral, 2013) . HIV-related stigma may, however, have wider ranging complications, if discrimination resulting from one's HIV serostatus is associated with fear of what may happen if diagnosed with other illnesses, and hence, lower health-care utilization for those potential comorbidities (Andrasik, Rose, Pereira, & Antoni, 2008; Earnshaw et al., 2013) .
The wider impact of enacted HIV-related stigma is important to characterize among African American women, who experience worse morbidity and mortality than others in relation to multiple non-AIDS defining illnesses. For example, African American women experience more advanced stages at diagnosis and a 44% higher mortality rate for breast cancer than their non-Latina White (NLW) counterparts (Howlader et al., 2014) . Causes of these disparities are multifactorial (Daly & Olopade, 2015) . Two wellstudied modifiable factors include breast-health beliefs (e.g., perceived threat of breast cancer) and regular breast health-care engagement. Perceived threat of breast cancer (e.g., overestimated risk, fatalistic attitudes about the survivability of breast cancer, perceptions about adverse intrapersonal and interpersonal consequences of a diagnosis) has been well-characterized among African American women (Davis, Thompson, Gutierrez, Boateng, & Jandorf, 2002; Hall et al., 2008; Powe & Finnie, 2003) . Further, perceived threat of breast cancer has been linked to lower engagement in breast-cancer care and poor breast-cancer outcomes (Bowen, Hickman, & Powers, 2014; Hall et al., 2008; Jones, Katapodi, & Lockhart, 2015; Karcher, Fitzpatrick, Leonard, & Weber, 2014; Peek, Sayad, & Markwardt, 2008) . Regular breast health-care engagement has been similarly well-characterized among African American women and has been tied to poor breast-cancer outcomes (Daly & Olopade, 2015; Jones et al., 2014; Miranda, Tarraf, González, Johnson-Jennings, & González, 2012; Peek et al., 2008; Smith-Bindman et al., 2006) . Enacted HIV-related stigma may be a unique predictor of greater perceived threat of breast cancer and irregular breast health-care engagement among African American women living with HIV, as history of discrimination as a result of one's HIV serostatus may lead to negative appraisals of other illnesses and lower health-care engagement overall.
Given the important, concurrent problems of HIV and breastcancer disparities for African American women, in the current study, we assessed the relationship of enacted HIV-related stigma to appraisals of breast cancer and regular breast health-care engagement among a sample of African American women living with HIV. Theoretical frameworks concerning how stigma affects health at large may be useful for understanding the relationship and potential mechanisms (Chambers et al., 2015; Earnshaw et al., 2013; Valdiserri, 2002) . Internalized HIV-related stigma and depressive symptoms are two important potential mechanisms. Internalized HIV-related stigma is defined here as "endorsing negative feelings and beliefs associated with HIV and applying them to the self" (Earnshaw et al., 2013 (Earnshaw et al., , p. 1786 . To note, internalized HIV-related stigma and depressive symptoms are common consequences of enacted HIV-related stigma (Lee, Kochman, & Sikkema, 2002; Rao, Kekwaletswe, Hosek, Martinez, & Rodriguez, 2007; Turan et al., 2017) . Internalized HIV-related stigma has been tied to adherence to recommended HIV treatment (Earnshaw et al., 2013) . Relevant to breast health care, some researchers have suggested that individuals with high levels of internalized HIVrelated stigma may be nonadherent to HIV care, in part because of feeling unworthy of care. In line with this, internalized stigma may be associated with greater perceived threat of breast cancer and lower regular breast health-care engagement in part, as a result of negative overall self-concepts (e.g., self-efficacy in fighting to survive; personal responsibility/attribution in others' stigmatizing behavior) as well as greater social isolation/distrust of providers in general (Darlington & Hutson, 2017; Hatzenbuehler, Phelan, & Link, 2013; Turan et al., 2017) . Alternatively, internalized HIVrelated stigma may affect breast health care through its impact on psychological health, including depressive symptoms (Earnshaw et al., 2013) . Depressive symptoms have been previously associated with lower engagement in breast health care (Consedine & Moskowitz, 2007; Husaini et al., 2001; Mitchell et al., 2014) , in part because of fatalistic anticipations/greater perceived threat of breast cancer, low self-esteem, and passive acceptance of negative events to come (Keshavarz, Simbar, Ramezankhani, & Alavi Majd, 2012; Magai, Consedine, Neugut, & Hershman, 2007) .
Given this literature, we developed a conceptual framework (see Figure 1 ). Overall, we hypothesized that experiences with discrimination, stereotyping, and prejudice related to one's HIV serostatus may lead to greater perceived threat of breast cancer and lower regular breast health-care engagement. These associations are hypothesized to occur partly because of endorsement and application of negative feelings and beliefs concerning HIV to the self and greater levels of depressive symptoms. We provide preliminary evidence concerning these hypotheses through a secondary data analysis of baseline data from an intervention trial aimed at reducing internalized HIV-related stigma among African American women living with HIV (Unity Workshop). Specifically, we (a) examined the relationships enacted HIV-related stigma has with perceived threat of breast cancer and regular breast health-care engagement and (b) assessed the mediating roles of internalized HIV-related stigma and depressive symptoms. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Method Procedures
Our data come from the baseline evaluation of a prospective study of a stigma-reduction intervention in Chicago, Illinois and Birmingham, Alabama. All materials and processes were approved by the institutional review boards of all participating institutions in Chicago and Birmingham. Baseline data collection occurred between October 2014 and October 2015. Participants were recruited from one county-and two university-affiliated clinics in Chicago and Birmingham providing medical care for patients living with HIV. Women over the age of 18 who self-identified as African American, had medically documented HIV seropositive status, and were receiving HIV health care were eligible. Our sample included relatively young women in the context of breast cancer, but women living with HIV and African American women in general are diagnosed with breast cancer at earlier ages than other women (Amir, Kaaya, Kwesigabo, & Kiitinya, 2000; Amirikia, Mills, Bush, & Newman, 2011; Cubasch et al., 2013; DeSantis, Siegel, & Jemal, 2013a , 2013b McCarthy, Yang, & Armstrong, 2015) .
Flyers with information about the study and contact information for a research coordinator were posted at study site clinics. Clinic physicians, counselors, and nurses also informed eligible participants about the study during clinic appointments and provided them with a research coordinator's contact information. In addition, when eligible women presented for their clinic appointments, research coordinators were paged to come to the clinic and verbally describe study procedures. Participants who agreed to participate were scheduled for individual meetings with a research coordinator for a thorough explanation of the study and to sign an informed-consent form. After consenting to the study, participants completed a battery of baseline assessments on a tablet computer. Participants could either read questions themselves, have questions read to them via headphones, or have a site representative assist them. For the parent study, participants received a total of $210, distributed across three group sessions and six survey assessments. For the data presented in the current study, women received $20 for completion of the baseline survey assessment.
With regard to data storage and security, documents with patient-identifying information and the coding key linking participant names to assigned study numbers were kept in a locked and secure file cabinet and/or password-protected computers and accessible only to study personnel. De-identified data sets were stored on a password-protected, encrypted shared drive accessible only to study personnel.
Measures
Demographic and clinical factors. Standard questions were used to obtain self-report data on age, educational attainment, marital status (never married vs. other), responsibility for any children within the home (any children vs. none), and living situation (living alone vs. other). State of residence (Illinois, Alabama) and study arm (intervention, control) were identified from study records. With regard to clinical variables, women were asked about the number of years since their diagnoses with HIV and family history of breast cancer (any vs. none).
HIV-Related Stigma. To assess HIV-related stigma, we used the 14-item version of the Stigma Scale for Chronic Illness (SSCI) instrument adapted to the specific experiences of populations living with HIV, and African American women in particular (Rao et al., 2016) . Women were asked to think about how they had felt in the past month with regard to their HIV infection and respond to these items. The two 8-item and 6-item subscales, respectively, measured Enacted and Internalized HIV-Related Stigma. response categories were 1 ϭ Never to 5 ϭ Always. Summary variables were sums of relevant items. Cronbach's ␣s for Enacted and Internalized HIV-Related Stigma for this sample were .89 and .91, respectively. Higher scores indicated more enacted and internalized HIV stigma.
Perceived Threat of Breast Cancer. To assess the perceived threat of breast cancer, we administered three subscales from the Champion's Health Belief Model and Breast Cancer scales (Champion, 1993; Champion et al., 2004) : Perceived Susceptibility of Being Diagnosed With Breast Cancer (Cronbach's ␣ for this sample ϭ .77), Fear of Breast Cancer (Cronbach's ␣ for this sample ϭ .74), and Perceived Adverse Consequences of Breast Cancer (Cronbach's ␣ for this sample ϭ .69). Response categories for all subscales ranged from 1 ϭ Strongly Disagree to 4 ϭ Strongly Agree. Summary variables for each subscale were averages of their respective items. Higher scores indicated greater Perceived Breast-Cancer Susceptibility, more Fear of Breast Cancer, and more Perceived Adverse Consequences of Breast Cancer. Finally, we calculated an overall score of Perceived Threat of Breast Cancer (Kohler et al., 2017) , which was an average of items from the three subscales.
Regular breast health-care engagement. To assess regular breast-cancer health-care engagement, we asked women about their clinical breast exam (CBE) history (0 ϭ Never, 1 ϭ Yes, if I have a complaint, 2 ϭ Once in a year, 3 ϭ Other). The variable was dichotomized such that 0 ϭ Never/If complaint/ Other and 1 ϭ Once in a year. Important to note, we were using CBEs as a proxy for engaging in regular breast-cancer health care and not as a form of screening, for which the United States Preventive Services Task Force (USPSTF) has indicated there is insufficient evidence concerning its benefits and harms (USP-STF, 2009). Nonetheless, CBEs are ideal as a proxy for breastcancer health-care engagement in that they represent a discrete opportunity for the patient to interact with the provider about her breast health, regardless of her age and risk level. Such engagement may be particularly important for African American women diagnosed with HIV, given the younger ages of breast-cancer diagnoses for women with HIV and African American women in general, as well as reduced sensitivity to mammography in younger women (Amir et al., 2000; Amirikia et al., 2011; Cubasch et al., 2013; DeSantis et al., 2013a DeSantis et al., , 2013b McCarthy et al., 2015) . Such efforts may further help initiate conversations about breast-related health care, including risk assessment, discussion of symptomatic issues (e.g., lumps), and risk-informed decisions about when and what type of screening to obtain.
Depressive symptoms. We used the Personal Health Questionnaire Depression Scale (PHQ-8) to measure depressive symptoms (Kroenke et al., 2009) . Respondents were asked to indicate their moods over the past 2 weeks. Response categories ranged from 0 ϭ Not at all to 3 ϭ Nearly every day. The summary score was a sum of all items. Cronbach's ␣ for this sample was .88. Higher scores indicated more depressive symptoms. This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Analysis Plan
We had Յ3% missing data. As such, we used mean imputation for missing cases. We first describe our sample (see Table 1 ). Initial bivariate analyses suggested that educational attainment and family history of breast cancer were important covariates of the study variables of interest, so we adjusted for them in all models. With regard to our first hypothesis, we conducted multivariate linear and logistic regression, testing models to examine if enacted HIV-related stigma predicted perceived threat of breast cancer and regular breast health-care engagement, after adjusting for covariates. With regard to our second hypothesis, we first examined relationships between the independent variable (enacted HIVrelated stigma) and the mediators (internalized HIV-related stigma, depressive symptoms), as well as the mediators and the outcome variables (perceived threat of breast cancer, regular breast healthcare engagement). We subsequently conducted two mediation models using a SPSS macro, PROCESS, which initializes a Preacher & Hayes bias-corrected bootstrapping method and the traditional Sobel's test (Hayes, 2009 (Hayes, , 2013 (Hayes, , 2015 Hayes & Preacher, 2010; Preacher & Hayes, 2008) . With regard to statistical power, our sample size was slightly larger than most mediation studies (median sample size ϭ 187, range ϭ 107-352; Fritz & MacKinnon, 2007) . Using these methods, our sample of 237 would have .80 power to detect mediation if ␣ paths (predictor ¡ mediator) and ␤ paths (mediator ¡ outcome) were medium-large (Fritz & MacKinnon, 2007) , which was confirmed when we used MedPower to calculate post hoc power analyses, given our sample size. Specifically, our sample would have .80 power for models in which ␣ and ␤ paths had partial correlations of at least .20 and the direct path had a partial correlation of at least .18 (Kenny, 2016) . We conducted sensitivity analyses in which we replicated multivariate regression analyses with individual subscales of Perceived Threat of Breast Cancer. For these analyses, in addition to demographic and clinical characteristics, we included other subscales as covariates. For example, when examining the relationship between Internalized HIV-Related Stigma and Fear of Breast Cancer, we adjusted for Perceived Threat of Breast Cancer and Perceived Susceptibility of Breast Cancer. We finally conducted a sensitivity analysis, by which we assessed if Depression mediated relationships between Internalized HIV-Related Stigma and outcome variables, given relationships depicted in Figure 1 . Table 1 provides demographic and clinical characteristics of our analytic sample. The average age was 46.77 years (SD ϭ 10.44). Women had, on average, been living with HIV for 15.20 years (SD ϭ 7.23). Over a third of the women had less than a highschool education, were living alone, and were not married. Fortytwo percent of women indicated that they were responsible for at least one child in each of their homes. Of the entire sample, 45% reported a family history of breast cancer and 16% indicated that this person was a first-degree relative (i.e., mother or sister). The mean score for perceived susceptibility was 1.70 (SD ϭ 0.65). Approximately 45% were Alabama residents. In total, 49% had been randomized to the breast-cancer education study arm within the parent study. With regard to study variables of interest, mean scores were 11.51 (SD ϭ 6.23) for Enacted HIV-Related Stigma, 13.81 (SD ϭ 6.55) for Internalized HIV-Related Stigma, 2.14 (SD ϭ 0.55) for Perceived Threat of Breast Cancer, and 7.67 Given these findings, we conducted mediation models to examine the mediating roles of 
Results

Discussion
This study offers preliminary evidence concerning the potentially widespread effects of HIV-related stigma for other illnesses among African American women. Such findings are timely, given the growing number of internalized HIV-related stigma-reduction interventions being developed (Sengupta et al., 2011; Stangl et al., 2013) , as well as the emerging importance of non-AIDS-defining illnesses, such as breast cancer, among populations living with HIV. Further, these findings are important for improving the health and well-being of African Americans, who experience worse morbidity and mortality for many illnesses than other racial/ethnic groups in the United States, including HIV and breast cancer.
Our conceptual model was partially supported, such that experiencing discrimination, stereotyping, and prejudice because of one's HIV serostatus was associated with greater perceived threat of breast cancer via greater levels of internalized HIV-related stigma. Although enacted HIV-related stigma was not associated with regular breast health-care engagement in our sample, internalized HIV-related stigma was associated with engagement. The role of internalized HIV stigma for perceptions and beliefs of other illnesses may be an important focal point for future investigation. Little work to date has examined the "spillover" of HIV-related stigma for other conditions, but previous work has documented differences in severe illness appraisal and conceptions among African Americans. For example, previous studies have found that African American women report greater perceived threat of breast cancer than other ethnic groups, including greater fear and lower perceived survivability (Davis et al., 2002; Hall et al., 2008; Powe & Finnie, 2003) . This study suggests that African American ‫ءء‬ p Ͻ .001.
‫ءءء‬ p Ͻ .0001. This document is copyrighted by the American Psychological Association or one of its allied publishers.
women living with HIV may perceive breast cancer to be highly threatening because of greater cancer fear and perceptions about adverse consequences of a breast-cancer diagnosis, especially if they experience high levels of internalized HIV stigma. High levels of cancer fear and concern about adverse consequences of cancer may be problematic, as they are associated with nonadherence to recommended screening guidelines (Davis et al., 2002; Peek et al., 2008) . Interventions that seek to reduce fatalism as a barrier and improve screening among African Americans may also need to incorporate elements of the HIV experience among African American women who have HIV themselves. Indeed, the experiences women have as a result of their HIV serostatus and the consequent rejection and blame that may be internalized may result in a generalized fear of any type of health diagnosis. Further quantitative and qualitative work is warranted to confirm our findings and to test this hypothesis across other health conditions. Directly testing the posited mechanisms underlying the association of internalized HIV stigma, including individuals' self-perceptions and social isolation/distrust of the medical system, may lead to greater negative appraisals of other health conditions, and would be specifically helpful. In addition, it may be worthwhile to understand how this relationship is impacted by the disease progression, duration, and other characteristics of HIV. Depression symptomatology was associated with enacted HIVrelated stigma, perceived threat of breast cancer, and regular breast cancer health-care engagement within our sample. It was not, however, a significant mediator in final models. Multiple reasons may exist. First, internalized HIV-related stigma may have influenced results, given its strong association with depressive symptoms in general (Rao et al., 2012; Turan et al., 2017) . Nonetheless, when including depressive symptoms only in models, we did not find evidence of mediation. Other theoretical frameworks and models have indicated that depressive symptoms may mediate the impact of internalized HIV-related stigma (Earnshaw & Chaudoir, 2009; Earnshaw et al., 2013; Rao et al., 2012; Turan et al., 2017) . However, our analyses suggested that depressive symptoms did not mediate the relationships internalized HIV-related stigma had with either perceived threat of breast cancer or regular breast health-care engagement in our sample. Second, it may well be that depressive symptoms are mediators, but that the effect was too small to be detected (i.e., Ͻ8% of variance), and our sample was not sufficiently powered. Third, we did not measure depressive symptoms or other mood disorders prior to receipt of the HIV diagnosis. Our results may be because of an inability to disentangle depression that has resulted from internalized HIV-related stigma from depression related to other causes. Future longitudinal work is warranted to confirm patterns documented in our sample and explore how they relate to established relationships between stigma, mental health, and health-care outcomes in the context of HIV.
The current study has several limitations. First, the parent study used convenience-based sampling from clinical populations, which may affect the generalizability of our study. Second, the current study was cross-sectional and observational in nature. It is thus difficult to answer definitively the direction of the relationship between stigma and breast-health beliefs, as well as to account for potential third variables. Longitudinal and experimental studies are warranted to provide stronger support for the causal relationships by examining the temporal sequence of relationships between internalized HIV stigma, depressive symptoms, perceived threat of breast cancer, and medical record-confirmed breast-cancer practices. Third, the current study focused on the experiences of African American cisgender women living with HIV. These relationships may also be found among other types of women living with HIV, as well as for other conditions among African American and other men living with HIV. Fourth, the current study did not include a measure of breast-cancer stigma, although the measure concerning adverse consequences could potentially be related to perceived stigma. Future researchers should examine the relationships between these two types of stigma, as well as their relation to primary and specialty care. Such efforts might be particularly interesting with regard to internalized stigma among women diagnosed with both HIV and breast cancer. Finally, our study focused on regular breast health-care engagement, which is suitable for younger populations who may not be within universal breastcancer screening and care guidelines. Future studies are warranted, however, to examine if HIV-related stigma may be associated with guideline-concordant screening, diagnostics, and treatment for breast cancer among symptomatic and older populations. In line with this, future longitudinal studies may test our model more fully and across time, including assessing factors not measured in our study (e.g., general self-efficacy, tendency to assume responsibility for negative experiences, passivity, mistrust, breast-cancer outcomes, depression/mood disorders prior to receipt of an HIV diagnosis) and testing relationships that we were not powered to examine (e.g., mediating effects of breast-health beliefs).
Conclusion and Future Venues
Our study offers novel and important findings in the context of stigma. Specifically, our findings suggest that negative experiences with a particular diagnosis (HIV) may lead to greater negative appraisals of another diagnosis (breast cancer), in part because of internalization/self-rejection from the negative experiences of HIV. Our work further provides interesting preliminary data on how common consequences of enacted HIV stigma (e.g., internalized HIV stigma, depressive symptoms) relate to other types of health-care utilization (e.g., regular breast healthcare engagement). Future work is warranted to assess these nuanced, complex relationships further in the context of breast cancer, as well as other illnesses/potential comorbidities that people living with HIV may experience.
